Quarterly report pursuant to Section 13 or 15(d)

Consolidated Balance Sheet (Parenthetical)

v3.24.2
Consolidated Balance Sheet (Parenthetical) - USD ($)
$ in Millions
Jun. 30, 2024
Dec. 31, 2023
Assets    
Federal funds sold and securities borrowed or purchased under agreements to resell measured at fair value $ 167,835 $ 133,053
Trading account assets, pledged as collateral 151,737 130,815
Debt securities:    
Fair Value 466,636 496,597
Loans and leases, measured at fair value 3,197 3,569
Loans held for sale, measured at fair value 1,572 2,059
Other assets 15,314 11,861
Deposits in U.S. offices:    
Interest bearing, measured at fair value 370 284
Federal funds purchased and securities loans or sold under agreements to repurchase, at fair value 214,719 178,609
Short-term borrowings, measured at fair value 7,200 4,690
Accrued expenses and other liabilities, measured at fair value 15,064 11,473
Accrued expenses and other liabilities, reserve for unfunded lending commitments 1,104 1,209
Long-term debt, measured at fair value $ 46,875 $ 42,809
Shareholders’ equity    
Preferred stock, par value (in dollars per share) $ 0.01 $ 0.01
Preferred stock authorized (in shares) 100,000,000 100,000,000
Preferred stock issued (in shares) 4,013,928 4,088,099
Preferred stock outstanding (in shares) 4,013,928 4,088,099
Common stock, par value (in dollars per share) $ 0.01 $ 0.01
Common stock authorized (in shares) 12,800,000,000 12,800,000,000
Common stock issued (in shares) 7,774,753,442 7,895,457,665
Common stock outstanding (in shares) 7,774,753,442 7,895,457,665
Short-term borrowings $ 40,429 $ 32,098
Long-term debt 290,474 302,204
Consolidated VIEs    
Shareholders’ equity    
Short-term borrowings 3,343 2,957
Long-term debt 9,137 8,456
All other liabilities 22 19
Consolidated VIEs | Nonrecourse    
Shareholders’ equity    
Short-term borrowings 0 23
Long-term debt 9,137 8,456
All other liabilities $ 22 $ 19